+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tiratricol"

Tiratricol (CAS 51-24-1) Global Market Research Report 2024 - Product Thumbnail Image

Tiratricol (CAS 51-24-1) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Tiratricol is a drug used to treat endocrine and metabolic disorders. It is a synthetic form of the thyroid hormone triiodothyronine (T3) and is used to treat hypothyroidism, a condition in which the body does not produce enough thyroid hormone. It is also used to treat myxedema coma, a rare and life-threatening form of hypothyroidism. Tiratricol is available in both oral and injectable forms. Tiratricol is a popular drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including hypothyroidism, myxedema coma, and other thyroid-related disorders. It is also used to treat obesity, as it helps to increase metabolism and reduce fat storage. The market for Tiratricol is highly competitive, with many companies offering the drug. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies that offer Tiratricol include Mylan, Teva, and Sun Pharmaceuticals. Show Less Read more